218 related articles for article (PubMed ID: 2274814)
1. [Thymus gland pathology in myasthenia gravis: cause or consequence?].
Zaĭrat'iants OV; Vetshev PS; Khavinson VKh; Ippolitov IKh; Shakhova OV
Sov Med; 1990; (8):18-25. PubMed ID: 2274814
[TBL] [Abstract][Full Text] [Related]
2. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Bcl-2 protein in the myasthenic thymus.
Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
[TBL] [Abstract][Full Text] [Related]
5. Involution of the thymus: a possible diagnostic pitfall.
Raica M; Cîmpean AM; Encică S; Cornea R
Rom J Morphol Embryol; 2007; 48(2):101-6. PubMed ID: 17641795
[TBL] [Abstract][Full Text] [Related]
6. [Role of the thymus in the physiopathology of myasthenia].
Eymard B; Berrih-Aknin S
Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132
[TBL] [Abstract][Full Text] [Related]
7. [The morphological and clinico-immunological characteristics of 2 types of myasthenia].
Zaĭrat'iants OV; Vetshev PS; Ippolitov IKh; Shkrob LO; Belokrinitskiĭ DV; Khodzhaev ZSh; Radenska-Lopovok SG
Arkh Patol; 1991; 53(8):22-7. PubMed ID: 1953371
[TBL] [Abstract][Full Text] [Related]
8. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis and horror autotoxicus. A review of the current literature with two case presentations.
Davis E
Proc Aust Assoc Neurol; 1971; 8():23-7. PubMed ID: 5153466
[No Abstract] [Full Text] [Related]
11. Clinical syndromes associated with thymic disorders.
Barnes EW; Irvine WJ
Proc R Soc Med; 1973 Feb; 66(2):151-4. PubMed ID: 4581989
[No Abstract] [Full Text] [Related]
12. Thymic remodeling associated with hyperplasia in myasthenia gravis.
Le Panse R; Bismuth J; Cizeron-Clairac G; Weiss JM; Cufi P; Dartevelle P; De Rosbo NK; Berrih-Aknin S
Autoimmunity; 2010 Aug; 43(5-6):401-12. PubMed ID: 20402580
[TBL] [Abstract][Full Text] [Related]
13. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
Simpson JA
Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological heterogeneity of autoimmune myasthenia gravis.
Pal J; Rozsa C; Komoly S; Illes Z
J Neuroimmunol; 2011 Feb; 231(1-2):43-54. PubMed ID: 21093931
[TBL] [Abstract][Full Text] [Related]
16. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
[TBL] [Abstract][Full Text] [Related]
17. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients.
Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C
J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484
[TBL] [Abstract][Full Text] [Related]
18. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
19. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
20. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
